Optimization of methylated DNA markers to rule out endometrial cancer…
A simple two-marker blood test from vaginal fluid can detect endometrial cancer with 96% accuracy, potentially sparing some women from invasive procedures.
- Lab
- Preclinical
- Early trials
- Late trials
- In practice
Functionally high-risk disease is associated with poor outcomes after…
Identifying multiple myeloma patients at highest risk early may help doctors decide to offer CAR T therapy sooner, when it might be most effective.
Novel or significantly improved treatmentAutologous CD19/BCMA CAR-T cell therapy for myasthenia gravis
A specialized immune cell therapy brought sustained improvement to patients with severely treatment-resistant myasthenia gravis, even allowing some to stop steroids.
Standard additionPresurgical levels of circulating tumour DNA in patients with…
A cheap blood test measuring tumor DNA before surgery can identify which colorectal cancer patients need closer monitoring after treatment.
Standard additionGenomic Determinants of Response to Alpelisib Plus Fulvestrant in the…
Genetic patterns beyond standard testing can predict which hormone-receptor-positive breast cancer patients will respond best to a targeted drug combination.